Skip to main content

Table 5 Systemic inflammation

From: Effect of deep tissue laser therapy treatment on peripheral neuropathic pain in older adults with type 2 diabetes: a pilot randomized clinical trial

Test Group Pre-test Post-test Percent Change p-value
Mean +/− SD Mean +/− SD
IL-6 DTLT 0.84 0.54 0.67 0.27 −20% = 0.038
SLT 0.71 0.11 0.65 0.13 −8% = 0.037
MCP-1 DTLT 4.91 1.59 4.10 1.25 −7% = 0.037
SLT 4.34 1.22 4.15 0.92 −4% = 0.581
RANTES DTLT 631.50 198.37 570.93 184.54 −10% = 0.364
SLT 651.80 205.56 606.56 164.92 −7% = 0.482
TNF-α DTLT 0.44 0.06 0.49 0.11 + 11% = 0.099
SLT 0.44 0.07 0.47 0.12 + 7% = 0.285
  1. IL-6 interleukin-6, MCP-1 monocyte chemoattractant protein-1, RANTES regulated on activation, normally T-cell expressed and secreted, TNF-α tumour necrosis factor alpha